$Progenity, Inc.(PROG)$ As you see,this buy out is so obvious and arythiumia is the king of selling acquiring and selling biotech. this company has a lot of intellectual property that big pharma wants to use and streamline.I will buy more, but I’m already in at 1.42. Mabye that buy out will come before the end of the month.
精彩评论